Search the collection

5 results for Makharadze,+Tamta

Sort by:

Sort by

Limit results to:

20 per page

5 results for Makharadze,+Tamta

Export to excel

Export record to excel

File type to download

Beta version

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 1
ArticlesPeer ReviewedFull Text
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial
Author / Creator:Kelley, Robin Kate, Prof ; Rimassa, Lorenza, MD ; Cheng, Ann-Lii, Prof ; Kaseb, Ahmed, Prof ; Qin, Shukui, Prof ; Zhu, Andrew X, Prof ; Chan, Stephen L, Prof ; Melkadze, Tamar, MD ; Sukeepaisarnjaroen, Wattana, MD ; Breder, Valery, MD ; Verset, Gontran, MD ; Gane, Edward, Prof ; Borbath, Ivan, Prof ; Rangel, Jose David Gomez, MD ; Ryoo, Baek-Yeol, Prof ; Makharadze, Tamta, MD ; Merle, Philippe, Prof ; Benzaghou, Fawzi, MD ; Banerjee, Kamalika, MSc ; Hazra, Saswati, PhD ; Fawcett, Jonathan, PhD ; Yau, Thomas, MD
Publisher:England: Elsevier Ltd
Journal title:The lancet oncology, 2022-08, Vol.23 (8), p.995-1008
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 2
ArticlesPeer ReviewedFull Text
Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial
Author / Creator:Gogishvili, Miranda ; Melkadze, Tamar ; Makharadze, Tamta ; Giorgadze, Davit ; Dvorkin, Mikhail ; Penkov, Konstantin ; Laktionov, Konstantin ; Nemsadze, Gia ; Nechaeva, Marina ; Rozhkova, Irina ; Kalinka, Ewa ; Gessner, Christian ; Moreno-Jaime, Brizio ; Passalacqua, Rodolfo ; Li, Siyu ; McGuire, Kristina ; Kaul, Manika ; Paccaly, Anne ; Quek, Ruben G. W. ; Gao, Bo ; Seebach, Frank ; Weinreich, David M. ; Yancopoulos, George D. ; Lowy, Israel ; Gullo, Giuseppe ; Rietschel, Petra
Publisher:New York: Nature Publishing Group US
Journal title:Nature medicine, 2022-11, Vol.28 (11), p.2374-2380
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 3
ArticlesPeer ReviewedFull Text
Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial
Author / Creator:Sezer, Ahmet ; Kilickap, Saadettin ; Gümüş, Mahmut ; Bondarenko, Igor ; Özgüroğlu, Mustafa ; Gogishvili, Miranda ; Turk, Haci M ; Cicin, Irfan ; Bentsion, Dmitry ; Gladkov, Oleg ; Clingan, Philip ; Sriuranpong, Virote ; Rizvi, Naiyer ; Gao, Bo ; Li, Siyu ; Lee, Sue ; McGuire, Kristina ; Chen, Chieh-I ; Makharadze, Tamta ; Paydas, Semra ; Nechaeva, Marina ; Seebach, Frank ; Weinreich, David M ; Yancopoulos, George D ; Gullo, Giuseppe ; Lowy, Israel ; Rietschel, Petra
Publisher:England: Elsevier Ltd
Journal title:The Lancet (British edition), 2021-02, Vol.397 (10274), p.592-604
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 4
ArticlesPeer ReviewedFull Text
Candidate Bevacizumab Biosimilar CT-P16 versus European Union Reference Bevacizumab in Patients with Metastatic or Recurrent Non-Small Cell Lung Cancer: A Randomized Controlled Trial
Author / Creator:Verschraegen, Claire ; Andric, Zoran ; Moiseenko, Fedor ; Makharadze, Tamta ; Shevnya, Sergii ; Oleksiienko, Alona ; Yañez Ruiz, Eduardo ; Kim, SungHyun ; Ahn, KeumYoung ; Park, TaeHong ; Park, Sijin ; Ju, Hana ; Ohe, Yuichiro
Publisher:Cham: Springer International Publishing
Journal title:BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2022-11, Vol.36 (6), p.749-760
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 5
ArticlesPeer ReviewedFull Text
Efficacy, Safety and Immunogenicity of MB02 (Bevacizumab Biosimilar) versus Reference Bevacizumab in Advanced Non-Small Cell
Author / Creator:Trukhin, Dmytro ; Poddubskaya, Elena ; Andric, Zoran ; Makharadze, Tamta ; Bellala, Ravi Shankar ; Charoentum, Chaiyut ; Yañez Ruiz, Eduardo P ; Fulop, Andrea ; Hyder Ali, Irfhan Ali ; Syrigos, Kostas ; Katgi, Nuran ; Chuken, Yamil Alonso Lopez ; Rumyana, Ilieva ; Reyes-Igama, Jasmin ; Costamilan, Rita De cassia ; García, Ana Del Campo ; Florez, Amalia ; Paravisini, Alexandra ; Millan, Susana
Publisher:Auckland: Springer Nature B.V
Journal title:BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2021-07, Vol.35 (4), p.429-444
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Export record to excel

Export this record

Export record to excel

Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial

Export this record

Export record to excel

Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial

Export this record

Export record to excel

Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial

Export this record

Export record to excel

Candidate Bevacizumab Biosimilar CT-P16 versus European Union Reference Bevacizumab in Patients with Metastatic or Recurrent Non-Small Cell Lung Cancer: A Randomized Controlled Trial

Export this record

Export record to excel

Efficacy, Safety and Immunogenicity of MB02 (Bevacizumab Biosimilar) versus Reference Bevacizumab in Advanced Non-Small Cell

Refine your search